Induction of WNT11 by hypoxia and hypoxia-inducible factor-1α regulates cell proliferation, migration and invasion

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Mori, Hiroyuki ^a   Yao, Yao ^a   Learman, Brian S ^a   Kurozumi, Kazuhiko ^b   Ishida, Joji ^b   Ramakrishnan, Sadeesh K ^a   Overmyer, Katherine A ^a   Xue, Xiang ^a   Cawthorn, William P ^a,c   Reid, Michael A ^a   Taylor, Matthew ^a   Ning, Xiaomin ^a,d   Shah, Yatrik M ^a   MacDougald, Ormond A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NORTHWEST A F UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ARNT PROTEIN, MOUSE; BEVACIZUMAB; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; OXYGEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A; VHL PROTEIN, MOUSE; VON HIPPEL LINDAU PROTEIN; WNT PROTEIN; WNT11 PROTEIN, MOUSE;

ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CELL HYPOXIA; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HELA CELL LINE; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PHYSIOLOGY; PROTEIN SYNTHESIS; TUMOR CELL LINE; TUMOR INVASION;

ANGIOGENESIS INHIBITORS; ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BEVACIZUMAB; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; PROTEIN BIOSYNTHESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN; WNT PROTEINS;

EID: 84958034198     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21520     Document Type: Article

References (56)

1. Dunwoodie, S. L. The role of hypoxia in development of the Mammalian embryo. Dev Cell 17, 755-773 (2009).
2. Semenza, G. L. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408 (2012).
3. Greer, S. N., Metcalf, J. L., Wang, Y., Ohh, M. The updated biology of hypoxia-inducible factor. Embo J 31, 2448-2460 (2012).
4. Ratcliffe, P. J. Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer. J Physiol 591, 2027-2042 (2013).
5. Lendahl, U., Lee, K. L., Yang, H., Poellinger, L. Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet 10, 821-832 (2009).
6. Keith, B., Johnson, R. S., Simon, M. C. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12, 9-22 (2012).
7. Chung, A. S., Ferrara, N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27, 563-584 (2011).
8. Lim, J. H., Chun, Y. S., Park, J. W. Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin. Cancer Res 68, 5177-5184 (2008).
9. Mazumdar, J. et al. O2 regulates stem cells through Wnt/beta-catenin signalling. Nat Cell Biol 12, 1007-1013 (2010).
10. MacDonald, B. T., Tamai, K., He, X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17, 9-26 (2009).
11. Willert, K., Nusse, R. Wnt proteins. Cold Spring Harb Perspect Biol 4, a007864 (2012).
12. Uysal-Onganer, P., Kypta, R. M. Wnt11 in 2011-the regulation and function of a non-canonical Wnt. Acta Physiol (Oxf) 204, 52-64 (2012).
13. Eisenberg, C. A., Eisenberg, L. M. WNT11 promotes cardiac tissue formation of early mesoderm. Dev Dyn 216, 45-58 (1999).
14. Summerhurst, K., Stark, M., Sharpe, J., Davidson, D., Murphy, P. 3D representation of Wnt and Frizzled gene expression patterns in the mouse embryo at embryonic day 11.5 (Ts19). Gene Expr Patterns 8, 331-348 (2008).
15. Ouko, L., Ziegler, T. R., Gu, L. H., Eisenberg, L. M., Yang, V. W. Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells. J Biol Chem 279, 26707-26715 (2004).
16. Heisenberg, C. P. et al. Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation. Nature 405, 76-81 (2000).
17. Pandur, P., Lasche, M., Eisenberg, L. M., Kuhl, M. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418, 636-641 (2002).
18. Majumdar, A., Vainio, S., Kispert, A., McMahon, J., McMahon, A. P. Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development 130, 3175-3185 (2003).
19. Abdul-Ghani, M. et al. Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals. Mol Cell Biol 31, 163-178 (2011).
20. Matthews, H. K., Broders-Bondon, F., Thiery, J. P., Mayor, R. Wnt11r is required for cranial neural crest migration. Dev Dyn 237, 3404-3409 (2008).
21. Hardy, K. M. et al. Non-canonical Wnt signaling through Wnt5a/b and a novel Wnt11 gene, Wnt11b, regulates cell migration during avian gastrulation. Dev Biol 320, 391-401 (2008).
22. Uysal-Onganer, P. et al. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells. Mol Cancer 9, 55 (2010).
23. Keunen, O. et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci USA 108, 3749-3754 (2011).
24. Conley, S. J. et al. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci USA 109, 2784-2789 (2012).
25. Ishida, J. et al. Integrin inhibitor suppresses bevacizumab-induced glioma invasion. Transl Oncol 7, 292-302 e291 (2014).
26. Morfoisse, F. et al. Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1alpha-independent translationmediated mechanism. Cell Rep 6, 155-167 (2014).
27. Raval, R. R. et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 25, 5675-5686 (2005).
28. Fujiwara, S. et al. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 30, 793-802 (2007).
29. Sullivan, R., Graham, C. H. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 26, 319-331 (2007).
30. Krishnamachary, B., Semenza, G. L. Analysis of hypoxia-inducible factor 1alpha expression and its effects on invasion and metastasis. Methods Enzymol 435, 347-354 (2007).
31. Wong, C. C. et al. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc Natl Acad Sci USA 108, 16369-16374 (2011).
32. Zhang, H. et al. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 31, 1757-1770 (2011).
33. Chaturvedi, P. et al. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J Clin Invest 123, 189-205 (2012).
34. Ulrich, F. et al. Slb/Wnt11 controls hypoblast cell migration and morphogenesis at the onset of zebrafish gastrulation. Development 130, 5375-5384 (2003).
35. De Calisto, J., Araya, C., Marchant, L., Riaz, C. F., Mayor, R. Essential role of non-canonical Wnt signalling in neural crest migration. Development 132, 2587-2597 (2005).
36. Witzel, S., Zimyanin, V., Carreira-Barbosa, F., Tada, M., Heisenberg, C. P. Wnt11 controls cell contact persistence by local accumulation of Frizzled 7 at the plasma membrane. J Cell Biol 175, 791-802 (2006).
37. Toyama, T., Lee, H. C., Koga, H., Wands, J. R., Kim, M. Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. Mol Cancer Res 8, 254-265 (2010).
38. Wu, B., Crampton, S. P., Hughes, C. C. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26, 227-239 (2007).
39. Ingraham, C. A., Park, G. C., Makarenkova, H. P., Crossin, K. L. Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels. J Biol Chem 286, 17649-17657 (2011).
40. Revuelta-Lopez, E. et al. Hypoxia induces metalloproteinase-9 activation and human vascular smooth muscle cell migration through low-density lipoprotein receptor-related protein 1-mediated Pyk2 phosphorylation. Arterioscler Thromb Vasc Biol 33, 2877-2887 (2013).
41. Park, Y. K. et al. Hypoxia-inducible factor-2alpha-dependent hypoxic induction of Wnt10b expression in adipogenic cells. J Biol Chem 288, 26311-26322 (2013).
42. Medley, T. L. et al. Effect of oxygen on cardiac differentiation in mouse iPS cells: role of hypoxia inducible factor-1 and Wnt/betacatenin signaling. PLoS One 8, e80280 (2013).
43. D'Uva, G. et al. Beta-catenin/HuR post-transcriptional machinery governs cancer stem cell features in response to hypoxia. PLoS One 8, e80742 (2013).
44. Gilkes, D. M. et al. Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells. Proc Natl Acad Sci USA 111, E384-393 (2014).
45. Desjardins, A. et al. Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas. Clin Cancer Res 14, 7068-7073 (2008).
46. Piao, Y. et al. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro Oncol 14, 1379-1392 (2012).
47. Feron, O. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 92, 329-333 (2009).
48. Zuo, S. et al. Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury. Stem cells and development 21, 598-608 (2012).
49. Dwyer, M. A. et al. WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res 70, 9298-9308 (2010).
50. Subauste, A. R., Elliott, B., Das, A. K., Burant, C. F. A role for 1-acylglycerol-3-phosphate-O-acyltransferase-1 in myoblast differentiation. Differentiation; research in biological diversity 80, 140-146 (2010).
51. Mori, H. et al. Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Invest 122, 2405-2416 (2012).
52. Troeberg, L., Nagase, H. Monitoring metalloproteinase activity using synthetic fluorogenic substrates. Current protocols in protein science/editorial board, John E Coligan [et al] Chapter 21, Unit 21, 16 (2004).
53. Snoek-van Beurden, P. A., Von den Hoff, J. W. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. BioTechniques 38, 73-83 (2005).
54. Hawkes, S. P., Li, H., Taniguchi, G. T. Zymography and reverse zymography for detecting MMPs and TIMPs. Methods in molecular biology 622, 257-269 (2010).
55. Kennell, J. A., O'Leary, E. E., Gummow, B. M., Hammer, G. D., MacDougald, O. A. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors. Mol Cell Biol 23, 5366-5375 (2003).
56. Xiang, L. et al. Hypoxia-inducible factor-2a is associated with ABCG2 expression, histology-grade and Ki67 expression in breast invasive ductal carcinoma. Diagn Pathol 7, 32 (2013).